Profit-Efficient Top Stocks to Buy Now

The bulls have held their ground in June after the furious rally off the stock market’s April lows.It’s difficult to know what, if anything, will shake the Nasdaq and the S&P 500 out of their recent holding patterns until the start of the second quarter earnings season in the middle of July.Thankfully, the bullish backdrop appears to remain intact as long as trade war progress continues, inflation remains in check, and corporate earnings grow.The last several months also highlight why investors must stay constantly exposed to the market and continue buying stocks even if broader sentiment turns bearish.A good starting point for investors looking to buy stocks in June is to find companies that boast improving earnings outlooks to help earn a Zacks Rank #1 (Strong Buy) that are also efficiently generating profits.Return on Equity 101Return on Equity or ROE helps investors understand if a firm’s executives are creating assets with investors’ cash or burning it. ROE shows a company’s ability to turn assets into profits. Put another way, this vital metric measures the profits made for each dollar of shareholder equity.ROE is calculated as net income / shareholder's equity. For example: if $0.10 of assets are created for each $1 of shareholder equity that would equal a ROE of 10%.Overall, Return on Equity is a great item to use regardless of what type of investor you are since it provides insight into management’s ability to create value and keep costs under control. Plus, if ROE slips, it can alert us to potential problems.With all that said, let’s take a look at this screen’s parameters and see the companies proving they can return value to shareholders instead of churning through their cash…• Zacks Rank equal to 1The Zacks Rank looks at upward earnings estimate revisions, among other metrics, in order to find companies that are projected to see their earnings get stronger. In fact, beginning with a Zacks Rank #1 can be a great starting point because it boasts an average annual return of over 25% per year during the last 30 years.• Price greater than or equal to 5Today we ruled out any stocks that are trading for less than $5 a share because they can be more volatile and speculative.• Price/Sales Ratio less than or equal to 1On top of that, we are looking for a low price to sales ratio. Today we went with 1 or below as this range is usually thought to provide better value since investors pay less for each unit of sales.• % (Broker) Rating Strong Buy equal to 100 (%)In this screen, we decided to go with companies that brokers are fully on board with since ratings are typically skewed strongly toward ‘buy’ and ‘strong buy.’• ROE greater than or equal to 10%Lastly, but most importantly for today’s screen, we got rid of any companies with Return on Equity of less than 10 because the median ROE value for all of the stocks in the Zacks Universe is under 10.Here is one of the seven stocks that made it through today’s screen…Buy This Market-Beating, Dividend Stock for Value and Profit EfficiencyMarubeni (MARUY) is a Japanese trading and investment conglomerate. MARUY, which trades OTC in the U.S., imports, exports, and trades a wide range of products, including food, chemicals, energy, metals, and machinery, across global markets. The company also invests in various industries, including real estate, power generation, and infrastructure projects. Additionally, Marubeni provides services such as finance, logistics, and resource development, operating through a vast network in nearly 70 countries.Image Source: Zacks Investment ResearchMARUY stock has ripped 250% higher in the past 10 years, blowing away the Zacks Conglomerates sector’s sideways movement and the S&P 500’s 200% climb. The stock recently hit all-time highs, and it’s attempting to break meaningfully above a trading range it’s been stuck in for several years. Despite its outperformance and charge to record highs, Marubeni trades at a 35% discount to its sector and 11% below its highs at 10.6X forward earnings.Image Source: Zacks Investment ResearchMarubeni’s ROE of 13.5% crushes its highly-ranked industry’s 3.13% average. On top of that, its 2.71% dividend yield is a great bonus for a stock that has easily beaten the benchmark over the last decade.Get the rest of the stocks on this list and start looking for the newest companies that fit these criteria. It's easy to do. And it could help you find your next big winner. Start screening for these companies today with a free trial to the Research Wizard. You can do it.Click here to sign up for a free trial to the Research Wizard today.Want more articles from this author? Scroll up to the top of this article and click the FOLLOW AUTHOR button to get an email each time a new article is published.Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. Disclosure: Performance information for Zacks’ portfolios and strategies are available at: www.zacks.com/performance_disclosureToday's Stocks from Zacks' Best ScreensStarting today, you can get instant access to the latest picks from our time-proven screens which since 2000 have soared far above the market. While the S&P 500 averaged +7.0% per year, we saw results like these: Small-Cap Growth +44.9%, Filtered Zacks Rank5 +48.4%, and Big Money Zacks +55.2%.You're invited to screen the latest stocks in seconds by trying Zacks' Research Wizard stock-picking program. Or use the Wizard to create your own market-beating strategies. No credit card needed, no cost or obligation.Try it for 2 weeks free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Marubeni Corp. (MARUY): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks